InvestSMART

AML3D Limited (ASX: AL3) - Announcements

Current share price for AL3 : $0.100 0.007 (6.98%)+

ASX company news and announcements for AML3D Limited (AL3) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AML3D Limited (AL3) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AML3D Limited (AL3), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AML3D Limited (AL3)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$57 US Navy Component Supplier Orders AML3D ARCEMY System 20 Sep 2023 9:06AM $0.083 $0.100 risen by 20.48%
$57 Managing Director and President US Operations Appointments 18 Sep 2023 9:03AM $0.080 $0.100 risen by 25%
$57 Notification regarding unquoted securities - AL3 13 Sep 2023 5:17PM $0.077 $0.100 risen by 29.87%
$57 AML3D Expands US Navy Submarine Parts Manufacturing 13 Sep 2023 9:15AM $0.077 $0.100 risen by 29.87%
$57 New US Defense Contract Expands AML3D Alloy Testing Program 12 Sep 2023 8:58AM $0.074 $0.100 risen by 35.14%
$57 Appendix 4G and Corporate Governance Statement 24 Aug 2023 9:58AM $0.095 $0.100 risen by 5.26%
$57 Annual Report to shareholders 24 Aug 2023 9:53AM $0.095 $0.100 risen by 5.26%
$57 FY23 Annual Report Release 24 Aug 2023 9:52AM $0.095 $0.100 risen by 5.26%
$57 Preliminary Final Report 24 Aug 2023 9:45AM $0.095 $0.100 risen by 5.26%
$57 AML3D Receives $2M Order from US Navy for Submarine Parts 16 Aug 2023 8:28AM $0.063 $0.100 risen by 58.73%
$57 US Defence Extends Testing Contract with AML3D 14 Aug 2023 9:35AM $0.069 $0.100 risen by 45.99%
$57 Notification of cessation of securities - AL3 4 Aug 2023 4:12PM $0.070 $0.100 risen by 42.86%
$57 AML3D August 2023 Update 3 Aug 2023 9:35AM $0.070 $0.100 risen by 42.86%
$57 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2023 9:19AM $0.065 $0.100 risen by 53.85%
$57 European Patent Granted 25 Jul 2023 9:13AM $0.068 $0.100 risen by 47.06%
$57 Arcemy Ordered for the US Navy's Center of Excellence 20 Jul 2023 9:22AM $0.054 $0.100 risen by 85.19%
$57 Application for quotation of securities - AL3 26 Jun 2023 3:38PM $0.055 $0.100 risen by 81.82%
$57 Cleansing Notice - Vested Performance Rights 26 Jun 2023 3:35PM $0.055 $0.100 risen by 81.82%
$57 Notification of cessation of securities - AL3 26 Jun 2023 3:35PM $0.055 $0.100 risen by 81.82%
$57 AML3D Advances Growth Strategy with Arcemy Sale 23 Jun 2023 9:12AM $0.055 $0.100 risen by 81.82%
$57 Management Changes 15 Jun 2023 9:34AM $0.060 $0.100 risen by 66.67%
$57 Business Update - US Pipeline Progress, Chevron Site Visit 1 Jun 2023 9:33AM $0.062 $0.100 risen by 61.29%
$57 Quarterly Activities/Appendix 4C Cash Flow Report 21 Apr 2023 8:51AM $0.082 $0.100 risen by 21.95%
$57 AML3D Scales up US Sales Capability and Access to Defence 17 Apr 2023 8:51AM $0.082 $0.100 risen by 21.95%
$57 Change of Director's Interest Notice - AS 13 Apr 2023 3:38PM $0.077 $0.100 risen by 29.87%

201 - 225 of 432 results

Page 9 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.